BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 17435957)

  • 41. Effects of soy isoflavones on menopausal neurovegetative symptoms.
    Colacurci N; Zarcone R; Borrelli A; De Franciscis P; Fortunato N; Cirillo M; Fornaro F
    Minerva Ginecol; 2004 Oct; 56(5):407-12. PubMed ID: 15531858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isoflavone treatment for acute menopausal symptoms.
    Cheng G; Wilczek B; Warner M; Gustafsson JA; Landgren BM
    Menopause; 2007; 14(3 Pt 1):468-73. PubMed ID: 17290160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial.
    Maki PM; Gast MJ; Vieweg AJ; Burriss SW; Yaffe K
    Neurology; 2007 Sep; 69(13):1322-30. PubMed ID: 17893293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Missing evidence for the effect one-week phytoestrogen-rich diet on mental rotation in two dimensions.
    Pilsáková L; Riecanský I; Ostatníková D; Jagla F
    Neuro Endocrinol Lett; 2009 Mar; 30(1):125-30. PubMed ID: 19300388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women.
    Gardner CD; Newell KA; Cherin R; Haskell WL
    Am J Clin Nutr; 2001 Apr; 73(4):728-35. PubMed ID: 11273847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hormone replacement therapy and cognitive function in postmenopausal women.
    Kurt M; Bekçi B; Karakaş S
    Maturitas; 2006 Jan; 53(1):39-48. PubMed ID: 16325023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women.
    Dunkin J; Rasgon N; Wagner-Steh K; David S; Altshuler L; Rapkin A
    Psychoneuroendocrinology; 2005 Apr; 30(3):284-96. PubMed ID: 15511602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Soymilk supplementation does not alter plasma markers of inflammation and oxidative stress in postmenopausal women.
    Beavers KM; Serra MC; Beavers DP; Cooke MB; Willoughby DS
    Nutr Res; 2009 Sep; 29(9):616-22. PubMed ID: 19854376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life.
    Almeida OP; Lautenschlager NT; Vasikaran S; Leedman P; Gelavis A; Flicker L
    Neurobiol Aging; 2006 Jan; 27(1):141-9. PubMed ID: 16298249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-term effects of a combination of isoflavones, lignans and Cimicifuga racemosa on climacteric-related symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled trial.
    Sammartino A; Tommaselli GA; Gargano V; di Carlo C; Attianese W; Nappi C
    Gynecol Endocrinol; 2006 Nov; 22(11):646-50. PubMed ID: 17145651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized isoflavone intervention among premenopausal women.
    Maskarinec G; Williams AE; Inouye JS; Stanczyk FZ; Franke AA
    Cancer Epidemiol Biomarkers Prev; 2002 Feb; 11(2):195-201. PubMed ID: 11867507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial].
    García-Martín A; Quesada Charneco M; Alvárez Guisado A; Jiménez Moleón JJ; Fonollá Joya J; Muñoz-Torres M
    Med Clin (Barc); 2012 Feb; 138(2):47-51. PubMed ID: 22024564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soy isoflavones, Mediterranean diet, and physical exercise in postmenopausal women with insulin resistance.
    Llaneza P; Gonzalez C; Fernandez-Iñarrea J; Alonso A; Diaz-Fernandez MJ; Arnott I; Ferrer-Barriendos J
    Menopause; 2010 Mar; 17(2):372-8. PubMed ID: 20216276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hot flashes and estrogen therapy do not influence cognition in early menopausal women.
    LeBlanc ES; Neiss MB; Carello PE; Samuels MH; Janowsky JS
    Menopause; 2007; 14(2):191-202. PubMed ID: 17194963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of dietary supplements on depressive symptoms in older patients: a randomised double-blind placebo-controlled trial.
    Gariballa S; Forster S
    Clin Nutr; 2007 Oct; 26(5):545-51. PubMed ID: 17662509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soy isoflavones and cognitive function.
    Lee YB; Lee HJ; Sohn HS
    J Nutr Biochem; 2005 Nov; 16(11):641-9. PubMed ID: 16169201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. One-year soy isoflavone supplementation prevents early postmenopausal bone loss but without a dose-dependent effect.
    Huang HY; Yang HP; Yang HT; Yang TC; Shieh MJ; Huang SY
    J Nutr Biochem; 2006 Aug; 17(8):509-17. PubMed ID: 16563719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of soy protein and isoflavones on blood pressure and endothelial cytokines: a 6-month randomized controlled trial among postmenopausal women.
    Liu ZM; Ho SC; Chen YM; Woo J
    J Hypertens; 2013 Feb; 31(2):384-92. PubMed ID: 23203140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Soy isoflavones in the management of postmenopausal osteoporosis.
    Atmaca A; Kleerekoper M; Bayraktar M; Kucuk O
    Menopause; 2008; 15(4 Pt 1):748-57. PubMed ID: 18277912
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial.
    Shah S; Bell RJ; Savage G; Goldstat R; Papalia MA; Kulkarni J; Donath S; Davis SR
    Menopause; 2006; 13(4):600-8. PubMed ID: 16837882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.